1.Marti Larriva PharmD Candidate June 13, 2013 2.   Patient Case  Background  Literature  Summary & Conclusions  Patient Case Outline 3.  Patient…

1.“ Top Down” therapy is NOT the best strategy for treating Crohn’s Disease – David G. Binion, M.D. Co-Director, Inflammatory Bowel Disease Center Director, Translational…

1. HepatologyPage 2 of 32Page 1Long-term entecavir therapy results in reversal of fibrosis/cirrhosis and continuedhistologic improvement in chronic hepatitis B patientsTing-Tsung…

1. REVA RALEIGH COLONNADE DST 100% Leased through 2023 7.39% average cash flow 13.97% expected IRR Class A Office Investment Opportunity in the heart of Tech-focused Raleigh,…

1. PHARMACEUTICALS M&A Tearsheet August 2015 Alps Venture Partners 2. 1pageA L P S V E N T U RE P A R T N E R S Merger & Acquisition Summary - Pharmaceuticals Valuation…

Credit Designation Purdue University College of Pharmacy designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only…

PowerPoint Presentation Robert Gish, MD Medical Director of the Hepatitis B Foundation San Diego, CA Program Disclosure This activity has been planned and implemented in…